01.02.2000 | Original Paper
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience
Erschienen in: Medical Oncology | Ausgabe 1/2000
Einloggen, um Zugang zu erhalten